CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses.

Journal:
Immunity
Published:
DOI:
10.1016/j.immuni.2021.04.006
Affiliations:
9
Authors:
26
Institutions Authors Share
QIMR Berghofer Medical Research Institute, Australia
10.000000
10.000000
0.38
Monash University, Australia
5.000000
0.19
La Trobe University, Australia
5.000000
0.19
The University of Queensland (UQ), Australia
3.500000
0.13
Australian Synchrotron, ANSTO, Australia
1.000000
0.04
Fiona Stanley Hospital (FSH), Australia
0.500000
0.02
The University of Western Australia (UWA), Australia
0.500000
0.02
Australian Infectious Diseases Research Centre (AID), Australia
0.500000
0.02